Role of tromaril--a new anti-inflammatory drug in eye diseases.

Abstract

In this clinical study, the role of enfenamic acid (Tromaril), a new anti-inflammatory and nonsteroidal drug, on various eye diseases such as trauma, on inflammatory diseases such as uveitis, and after cataract surgery was evaluated. The drug was administered to 30 patients (group A) while 29 patients (group B) were given a placebo. Twenty-one patients showed good response, and of these, 15 patients (76%) belonged to group A, to whom Tromaril had been administered. Of the patients who were given Tromaril, none showed any side effects in general. It can be concluded that Tromaril is a strong and effective anti-inflammatory drug for use in various eye diseases.

• Authors: K S Mehra, N Agrawal
• Journal: Annals of ophthalmology (Ann Ophthalmol) Vol. 16 Issue 2 Pg. 132-3 (Feb 1984) ISSN: 0003-4886 [Print] United States
• PMID: 6367599 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• ortho-Aminobenzoates
• enfenamic acid

Topics

• Choroiditis (drug therapy)
• Clinical Trials as Topic
• Double-Blind Method
• Eye Diseases (drug therapy)
• Humans
• Postoperative Care
• Random Allocation
• Uveitis, Anterior (drug therapy)
• ortho-Aminobenzoates (therapeutic use)